Lineage Cell Therapeutics Inc (NYSE American:LCTX)

1.31
Delayed Data
As of Dec 07
 -0.08 / -5.76%
Today’s Change
1.02
Today|||52-Week Range
2.71
-46.53%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Hogge Gary S
Sale12/28/2021501,588$2.45$1.2M-47.15%
Broadwood Capital Inc
Director
Buy3/25/2022470,000$1.44$676.8K-12.16%
Hogge Gary S
Buy12/28/2021236,899$2.11$499.9K-47.15%
Broadwood Capital Inc
Director
Buy3/23/2022260,106$1.37$356.3K-5.80%
Broadwood Capital Inc
Director
Buy3/24/2022200,000$1.42$284.0K-9.72%
Hogge Gary S
Buy12/28/2021185,000$0.69$127.7K-47.15%
Hogge Gary S
Buy12/28/202179,689$1.14$90.8K-47.15%
Hogge Gary S
Sale12/29/202128,445$2.44$69.4K-46.50%
Amin Dipti/quintiles/
Director
Buy3/28/202235,000$1.63$57.1K-12.16%
Hogge Gary S
Sale12/29/20219,250$2.49$23.0K-46.50%
Page of 2